Conferences

  Dionysia Kefala, PhD candidate at the ICT, participated in the 2nd Translational Research Conference: Immune & Cellular Therapies: Focus on Advanced Gene-Engineered Immune Cells in Berlin, Germany organized by the European School of Hematology on September 12-14, 2022.   Dionysia Kefala presented the study on

The Institute of Cell Therapy participated in the 9th International Conference on HLA-G in Paris (4&5 July 2022). The conference focused on the biology and clinical significance of the immunomodulatory molecule HLA-G in the fields of oncology, transplantation, autoimmune and other diseases.   PhD candidate

Prof. Alexandros Spyridonidis, Director and Dionysia Kefala, PhD candidate of the ICT, participated in the Annual Meeting ISCT 2022 San Fransisco, California, USA in May 2022.   Dionysia Kefala presented the study on “Pre-clinical development of a decitabine-induced regulatory HLAG+CD4+ T cell-enriched cell product (iG-Treg) against